Raza; Ali Patent Filings

Patent	Date
Methods And Systems For Displaying Media Listings App 20140245353 - Raza; Ali	2014-08-28
Primer compositions and methods of making the same App 20090297818 - Williams; Dale ; et al.	2009-12-03
Bookmarks for program note information App 20090119328 - Raza; Ali ; et al.	2009-05-07
Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyri- midin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 App 20090042911 - Pears; John S. ; et al.	2009-02-12
Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyri- midin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 App 20060040969 - Pears; John S. ; et al.	2006-02-23
Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4 Grant 6,982,157 - Pears , et al. January 3, 2	2006-01-03
Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia Grant 6,858,618 - Raza , et al. February 22, 2	2005-02-22
Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia App 20040072852 - Raza, Ali ; et al.	2004-04-15

Patent

Date

Methods And Systems For Displaying Media Listings
App 20140245353 - Raza; Ali

2014-08-28

Primer compositions and methods of making the same
App 20090297818 - Williams; Dale ; et al.

2009-12-03

Bookmarks for program note information
App 20090119328 - Raza; Ali ; et al.

2009-05-07

Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyri- midin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4
App 20090042911 - Pears; John S. ; et al.

2009-02-12

Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyri- midin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4
App 20060040969 - Pears; John S. ; et al.

2006-02-23

Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4
Grant 6,982,157 - Pears , et al. January 3, 2

2006-01-03

Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
Grant 6,858,618 - Raza , et al. February 22, 2

2005-02-22

Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
App 20040072852 - Raza, Ali ; et al.

2004-04-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

Raza; Ali

Patent Applications and Registrations